Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Talsaclidine

Generic Name: Talsaclidine

Drug Type: Small Molecule

Chemical Formula: C_₁₀H_₁₅NO

CAS Number: 147025-53-4

Unique Ingredient Identifier: 1O8VSL798T

Overview

Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.

Background

Talsaclidine has been used in trials studying the treatment of Alzheimer Disease.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) Administered Orally to Healthy Adult Male Volunteers

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

ID:NCT02264080

Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

ID:NCT02264093

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers

Phase 1

Completed

Posted: 2014/10/15

Sponsor:Boehringer Ingelheim

ID:NCT02264067

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Phase 2

Terminated

Posted: 2014/09/25

Sponsor:Boehringer Ingelheim

ID:NCT02248116

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Phase 2

Terminated

Posted: 2014/09/25

Sponsor:Boehringer Ingelheim

ID:NCT02249351

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy